Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:07:57.305Z.
Calculation as of: 2026-10-06T19:07:57.305Z.
Quote observation: 2026-10-06T19:05:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 833b8a33f5e3aa548e06775940c7a83493d9a3083fc648ecb3f8ecd80d633b38
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Quantum-Si incorporated
Market Cap
$246.29M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$245.36M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.96M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.47M
Free Cash Flow Yield
N/A
TTM Avg
12.33%
3Y Avg
12.33%
5Y Avg
12.33%
Market Cap
$243.67M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.12M
Free Cash Flow Yield
N/A
TTM Avg
1.67%
3Y Avg
1.64%
5Y Avg
2.28%
Market Cap
$238.13M
Free Cash Flow Yield
4.82%
TTM Avg
5.58%
3Y Avg
6.49%
5Y Avg
6.20%
Market Cap
$237.57M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum-Si incorporated (QSI) | $246.29M | N/A | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $245.36M | N/A | N/A | N/A | N/A |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $243.96M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $243.47M | N/A | 12.33% | 12.33% | 12.33% |
| Galectin Therapeutics Inc. (GALT)vs › | $243.67M | N/A | N/A | N/A | N/A |
| Upstream Bio, Inc. (UPB)vs › | $250.33M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.12M | N/A | 1.67% | 1.64% | 2.28% |
| High Tide Inc. (HITI)vs › | $238.13M | 4.82% | 5.58% | 6.49% | 6.20% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $237.57M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.16M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
